{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T11:27:04Z","timestamp":1786793224541,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":27,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ajt.2026.07.016","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:56:50Z","timestamp":1784735810000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Regulatory T cell modulation with selective CD28 blockade and IL-6 receptor antagonist in kidney transplant recipients: Results of CTOT-24\u2014a prospective clinical trial"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4547-3381","authenticated-orcid":false,"given":"Sindhu","family":"Chandran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7313-3574","authenticated-orcid":false,"given":"Qizhi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2528-9555","authenticated-orcid":false,"given":"Joey C.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian D.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9344-9928","authenticated-orcid":false,"given":"John J.","family":"Friedewald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2004-5962","authenticated-orcid":false,"given":"Allan D.","family":"Kirk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0511-8764","authenticated-orcid":false,"given":"Zoltan G.","family":"Laszik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8237-3094","authenticated-orcid":false,"given":"Megan","family":"Morsheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6701-4680","authenticated-orcid":false,"given":"Flavio G.","family":"Vincenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ajt.2026.07.016_bib1","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1111\/ajt.16386","article-title":"Optimization of de novo belatacept-based immunosuppression administered to renal transplant recipients","volume":"21","author":"Kirk","year":"2021","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.ajt.2026.07.016_bib2","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1600-6143.2009.03005.x","article-title":"A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study)","volume":"10","author":"Vincenti","year":"2010","journal-title":"Am J Transplant"},{"issue":"6029","key":"10.1016\/j.ajt.2026.07.016_bib3","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1126\/science.1202947","article-title":"Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4","volume":"332","author":"Qureshi","year":"2011","journal-title":"Science"},{"issue":"6440","key":"10.1016\/j.ajt.2026.07.016_bib4","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1126\/science.aav7062","article-title":"Restriction of PD-1 function by cis-PD-L1\/CD80 interactions is required for optimal T cell responses","volume":"364","author":"Sugiura","year":"2019","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.ajt.2026.07.016_bib5","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/j.1600-6143.2011.03929.x","article-title":"Deleterious effect of CTLA4-Ig on a Treg-dependent transplant model","volume":"12","author":"Riella","year":"2012","journal-title":"Am J Transplant"},{"issue":"30","key":"10.1016\/j.ajt.2026.07.016_bib6","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2023739118","article-title":"Treg-expressed CTLA-4 depletes CD80\/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells","volume":"118","author":"Tekguc","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"10.1016\/j.ajt.2026.07.016_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083139","article-title":"Targeting CD28, CTLA-4 and PD-L1 costimulation differentially controls immune synapses and function of human regulatory and conventional T-cells","volume":"8","author":"Dilek","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.ajt.2026.07.016_bib8","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1111\/j.1600-6143.2012.04032.x","article-title":"Vanhove, CD28-specific immunomodulating antibodies: what can be learned from experimental models?","volume":"12","author":"Poirier","year":"2012","journal-title":"Am J Transplant"},{"issue":"12","key":"10.1016\/j.ajt.2026.07.016_bib9","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1681\/ASN.2015070774","article-title":"Anti-CD28 antibody and belatacept exert differential effects on mechanisms of renal allograft rejection","volume":"27","author":"Ville","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ajt.2026.07.016_bib10","article-title":"Selective CD28 blockade impacts T cell differentiation during homeostatic reconstitution following lymphodepletion","volume":"13","author":"Habib","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.ajt.2026.07.016_bib11","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.96378","article-title":"Selective CD28 blockade attenuates CTLA-4-dependent CD8+ memory T cell effector function and prolongs graft survival","volume":"3","author":"Liu","year":"2018","journal-title":"JCI Insight"},{"issue":"7","key":"10.1016\/j.ajt.2026.07.016_bib12","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1111\/ajt.16459","article-title":"Interleukin-6 blockade with tocilizumab increases Tregs and reduces T effector cytokines in renal graft inflammation: a randomized controlled trial","volume":"21","author":"Chandran","year":"2021","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.ajt.2026.07.016_bib13","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1600-6143.2011.03770.x","article-title":"Critical role of proinflammatory cytokine IL-6 in allograft rejection and tolerance","volume":"12","author":"Zhao","year":"2012","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.ajt.2026.07.016_bib14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/jcph.791","article-title":"Pharmacokinetic, pharmacodynamic, and safety profile of a novel anti-CD28 domain antibody antagonist in healthy subjects","volume":"57","author":"Shi","year":"2017","journal-title":"J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.ajt.2026.07.016_bib16","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/imm.13115","article-title":"Helios: still behind the clouds","volume":"158","author":"Thornton","year":"2019","journal-title":"Immunology"},{"issue":"22","key":"10.1016\/j.ajt.2026.07.016_bib15","doi-asserted-by":"crossref","first-page":"12258","DOI":"10.1073\/pnas.1922600117","article-title":"Epigenetic conversion of conventional T cells into regulatory T cells by CD28 signal deprivation","volume":"117","author":"Mikami","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.ajt.2026.07.016_bib17","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/ni1160","article-title":"CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2","volume":"6","author":"Tai","year":"2005","journal-title":"Nat Immunol"},{"issue":"7","key":"10.1016\/j.ajt.2026.07.016_bib18","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.4049\/jimmunol.171.7.3348","article-title":"Cutting edge: CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells","volume":"171","author":"Tang","year":"2003","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.ajt.2026.07.016_bib19","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1111\/j.1600-6143.2008.02377.x","article-title":"The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantation","volume":"8","author":"Bluestone","year":"2008","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.ajt.2026.07.016_bib20","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0161-5890(95)00077-1","article-title":"Differential recognition by CD28 of its cognate counter receptors CD80 (B7.1) and B70 (B7.2): analysis by site-directed mutagenesis","volume":"33","author":"Truneh","year":"1996","journal-title":"Mol Immunol"},{"key":"10.1016\/j.ajt.2026.07.016_bib21","article-title":"CD28-selective inhibition prolongs non-human primate kidney transplant survival","author":"Lovasik","year":"2023","journal-title":"bioRxiv"},{"issue":"1","key":"10.1016\/j.ajt.2026.07.016_bib22","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/ajt.12964","article-title":"FR104, an antagonist anti-CD28 monovalent Fab' antibody, prevents alloimmunization and allows calcineurin inhibitor minimization in nonhuman primate renal allograft","volume":"15","author":"Poirier","year":"2015","journal-title":"Am J Transplant"},{"issue":"8","key":"10.1016\/j.ajt.2026.07.016_bib23","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1111\/j.1600-6143.2011.03624.x","article-title":"Selective CD28 blockade attenuates acute and chronic rejection of murine cardiac allografts in a CTLA-4-dependent manner","volume":"11","author":"Zhang","year":"2011","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.ajt.2026.07.016_bib24","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1097\/TP.0000000000002044","article-title":"Selective CD28 inhibition modulates alloimmunity and cardiac allograft vasculopathy in anti-CD154-treated monkeys","volume":"102","author":"Zhang","year":"2018","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.ajt.2026.07.016_bib25","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/tri.12658","article-title":"Clinical consequences of circulating CD28-negative T cells for solid organ transplantation","volume":"29","author":"Betjes","year":"2016","journal-title":"Transpl Int"},{"issue":"9","key":"10.1016\/j.ajt.2026.07.016_bib26","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1111\/ajt.14349","article-title":"Belatacept-resistant rejection is associated with CD28(+) memory CD8 T cells","volume":"17","author":"Mathews","year":"2017","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.ajt.2026.07.016_bib27","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1038\/s41467-024-48574-w","article-title":"IL-6 inhibition prevents costimulation blockade-resistant allograft rejection in T cell-depleted recipients by promoting intragraft immune regulation in mice","volume":"15","author":"Muckenhuber","year":"2024","journal-title":"Nat Commun"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613526026766?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613526026766?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T11:15:21Z","timestamp":1786792521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613526026766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":27,"alternative-id":["S1600613526026766"],"URL":"https:\/\/doi.org\/10.1016\/j.ajt.2026.07.016","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulatory T cell modulation with selective CD28 blockade and IL-6 receptor antagonist in kidney transplant recipients: Results of CTOT-24\u2014a prospective clinical trial","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajt.2026.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Society of Transplantation & American Society of Transplant Surgeons.","name":"copyright","label":"Copyright"}]}}